2 Smoking Cessation with a Pregnancy Population: A Pilot Program

Wednesday, August 15, 2012
Exhibit Hall (Kansas City Convention Center)
Dr. Amy Lukowski, Psy.D. , National Jewish Health, Denver, CO

Learning Objectives

At the conclusion of this presentation attendees will be able to:

  1. Describe cessation treatment indications for pregnant women

Audience: Individuals who deliver tobacco cessation services to women who are pregnant or post-partum Key Points: The key points were developed so that the audience understands the scope of the program for pregnant women who smoke and understand the program and services used to obtain a high quit rate for participants of the program. • Quitting smoking is the most important action a pregnant woman can take to ensure her own health and the health of her baby • Cigarette smoking exposes the pregnant woman to numerous chemicals that are clearly detrimental to the pregnancy and fetal development • Smoking prevalence rates of pregnant women • Relapse rates of post-partum women up to one year after delivery • Understand the components of a National Jewish Health pilot program to help pregnant women quit smoking and continue to support them postpartum including: o Working with a dedicated coach throughout the program o Receiving monetary incentives for completed calls during pregnancy and completed calls post-partum o For participant’s who received medical consent, 8 weeks of Nicotine Replacement Therapy o Text messaging post-partum Educational Experience: The audience will be provided didactic information on how the pilot program was delivered so that they might replicate the interventions in their own settings. Benefits: The audience will understand that 351 women were enrolled during various stages of their pregnancy. After one year, 109 of the participants were reached were found to have a cessation rate of 63% for this group.